MedTrace Logo

Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes

NCT00229268 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2012-06-01

No results posted yet for this study

Summary

The purpose of this study is to determine whether the level of FOXA2 expression in fat tissue is a biomarker of insulin resistance. To test this hypothesis, we will perform euglycemic-hyperinsulinemic clamps in normal and obese human subjects to calculate insulin sensitivity, and see if insulin sensitivity correlates with the FOXA2 expression in subcutaneous fat.

Conditions

Sponsors & Collaborators

  • Rockefeller University

    lead OTHER

Principal Investigators

  • Markus Stoffel, MD, PHD · Rockefeller University

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00229268 on ClinicalTrials.gov